Curaleaf (OTCMKTS:CURLF) Shares Gap Up – Should You Buy?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) gapped up before the market opened on Thursday . The stock had previously closed at $3.22, but opened at $3.40. Curaleaf shares last traded at $3.27, with a volume of 12,003 shares.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded Curaleaf from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 5th. Three research analysts have rated the stock with a Strong Buy rating and one has issued a Buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Strong Buy”.

Curaleaf Trading Down 2.1%

The firm has a market capitalization of $2.32 billion, a PE ratio of -25.54 and a beta of 1.58. The company has a current ratio of 1.56, a quick ratio of 0.74 and a debt-to-equity ratio of 1.05. The business has a fifty day moving average price of $2.87 and a two-hundred day moving average price of $2.66.

Curaleaf (OTCMKTS:CURLF) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.09 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.17. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%.The business had revenue of $324.23 million during the quarter, compared to analysts’ expectations of $316.62 million. Analysts expect that Curaleaf Holdings, Inc. will post -0.1 EPS for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.